Aggregate-data estimation of an individual patient data linear random effects meta-analysis with a patient covariate-treatment interaction term

Biostatistics

Volumn 14, Issue 2, 2013, Pages 273-283

  Kovalchik, Stephanie A ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

Author keywords

Clinical trials; Meta analysis; Random effects models; Statistical methods in Health service research

Indexed keywords

CHOLESTEROL; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; PRAVASTATIN;

ALGORITHM; ANALYSIS OF VARIANCE; ARTICLE; BAYES THEOREM; BIOSTATISTICS; BLOOD; COMPUTER PROGRAM; CORONARY ARTERY DISEASE; HUMAN; MALE; META ANALYSIS (TOPIC); PATHOLOGY; RANDOMIZED CONTROLLED TRIAL (TOPIC); STATISTICAL ANALYSIS; STATISTICAL MODEL; STATISTICS; TREATMENT OUTCOME;

ALGORITHMS; ANALYSIS OF VARIANCE; BAYES THEOREM; BIOSTATISTICS; CHOLESTEROL; CORONARY ARTERY DISEASE; DATA INTERPRETATION, STATISTICAL; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; LIKELIHOOD FUNCTIONS; LINEAR MODELS; MALE; META-ANALYSIS AS TOPIC; PRAVASTATIN; RANDOMIZED CONTROLLED TRIALS AS TOPIC; SOFTWARE; TREATMENT OUTCOME;

EID: 84874874407     PISSN: 14654644     EISSN: 14684357     Source Type: Journal    
DOI: 10.1093/biostatistics/kxs035     Document Type: Article

References (27)

1. BERLIN, J. A., SANTANNA, J., SCHMID, C. H., SZCZECH, L. A., FELDMAN, H. I. AND ANTI-LYMPHOCYTE ANTIBODY INDUCTION THERAPY STUDY GROUP. (2002). Individual patient- versus group-level data meta-regressions for the investigation of treatment effect modifiers: ecological bias rears its ugly head. Statistics in Medicine 21, 371-387..
2. BROOKES, S. T., WHITLEY, E., PETERS, T. J., MULHERAN, P. A., EGGER, M. AND DAVEY SMITH, G. (2001). Subgroup analyses in randomised controlled trials: quantifying the risks of false-positives and false-negatives. Health Technology Assessment 5, 1-56..
3. ENGELS, E. A., SCHMID, C. H., TERRIN, N., OLKIN, I. AND LAU, J. (2000). Heterogeneity and statistical significance in meta-analysis: an empirical study of 125 meta-analyses. Statistics in Medicine 19, 1707-1728..
4. FISHER, D. J., COPAS, A. J., TIERNEY, J. F. AND PARMAR, M. K. (2011). A critical review of methods for the assessment of patient-level interactions in individual participant data meta-analysis of randomized trials, and guidance for practitioners. Journal of Clinical Epidemiology 64, 949-967..
5. HARTLEY, H. O. AND RAO, J. N. K. (1967). Maximum-likelihood estimation for mixed analysis of variance model. Biometrika 54, 93-108..
6. HIGGINS, J. P. T. AND THOMPSON, S. G. (2002). Quantifying heterogeneity in a meta-analysis. Statistics in Medicine 21, 1539-1558..
7. HOMER, N., SZELINGER, S., REDMAN, M., DUGGAN, D., TEMBE, W., MUEHLING, J., PEARSON, J. V., STEPHAN, D. A., NELSON, S. F. AND CRAIG, D. W. (2008). Resolving individuals contributing trace amounts of DNA to highly complex mixtures using high-density SNP genotyping microarrays. PloS Genetics 4, e1000167..
8. JUKEMA, J. W., BRUSCHKE, A. V., VAN BOVEN, A. J., REIBER, J. H., BAL, E. T., ZWINDERMAN, A. H., JANSEN, H., BOERMA, G. J., VAN RAPPARD, F. M. AND LIE, K. I. (1995). Effects of lipid lowering by pravastatin on progression and regression of coronary artery disease in symptomatic men with normal to moderately elevated serum cholesterol levels. The Regression Growth Evaluation Statin Study (REGRESS). Circulation 91, 2528-2540..
9. KOOPMAN, L., VAN DER HEIJDEN, G. J., HOES, A. W., GROBBEE, D. E. AND ROVERS, M. M. (2008). Empirical comparison of subgroup effects in conventional and individual patient data meta-analyses. International Journal of Technology Assessment in Health Care 24, 358-361..
10. KOVALCHIK, S. A. (2012). Survey finds that most meta-analysts do not attempt to collect individual patient data. Journal of Clinical Epidemiology (in press)..
11. KOVALCHIK, S. A. AND CUMBERLAND, W. G. (2012).Using aggregate data to estimate the standard error of a treatmentcovariate interaction in an individual patient data meta-analysis. Biometrical Journal 54, 370-384..
12. LAGAKOS, S. W. (2006). The challenge of subgroup analyses-reporting without distorting. New England Journal of Medicine 354, 1667-1669..
13. LAIRD, N. M. AND WARE, J. H. (1982). Random-effects models for longitudinal data. Biometrics 38, 963-974..
14. LAMBERT, P. C., SUTTON, A. J., ABRAMS, K. R. AND JONES, D. R. (2002). A comparison of summary patient-level covariates in meta-regression with individual patient data meta-analysis. Journal of Clinical Epidemiology 55, 86-94..
15. LIN, D. C., AND ZENG, D. (2010). On the relative efficiency of using summary statistics versus individual-level data in meta-analysis. Biometrika 97, 321-332..
16. MATHEW, T. AND NORDSTR̈OM, K. (1999). On the equivalence of meta-analysis using literature and using individual patient data. Biometrics 55, 1221-1223..
17. OLKIN, I. AND SAMPSON, A. (1998). Comparison of meta-analysis versus analysis of variance of individual patient data. Biometrics 54, 317-322..
18. PINHEIRO, J. C. AND BATES, D. M. (2000). Mixed-effects Models in S and S-PLUS, Statistics and Computing. New York: Springer.
19. RILEY, R. D., LAMBERT, P. C., STAESSEN, J. C., WANG, J., GUEYFFIER, F., THIJS, L. AND BOUTITIE, F. (2008). Metaanalysis of continuous outcomes combining individual patient data and aggregate data. Statistics in Medicine 27, 1870-1893..
20. RILEY, R. D., SIMMONDS, M. C. AND LOOK, M. P. (2007). Evidence synthesis combining individual patient data and aggregate data: a systematic review identified current practice and possible methods. Journal of Clinical Epidemiology 60, 431-439..
21. ROTHWELL, P. M. (2005). Treating individuals 2. Subgroup analysis in randomised controlled trials: importance, indications, and interpretation. Lancet 365, 176-186..
22. SCHMID, C. H., STARK, P. C., BERLIN, J. A., LANDAIS, P. AND LAU, J. (2004). Meta-regression detected associations between heterogeneous treatment effects and study-level, but not patient-level, factors. Journal of Clinical Epidemiology 57, 683-697..
23. SCHULZ, K. F., ALTMAN, D. G., MOHER, D. AND THE CONSORT GROUP. (2010). CONSORT 2010 Statement: Updated guidelines for reporting parallel group randomized trials. Annals of Internal Medicine 152, 726-32..
24. SIMMONDS, M. C. AND HIGGINS, J. P. (2007). Covariate heterogeneity in meta-analysis: criteria for deciding between meta-regression and individual patient data. Statistics in Medicine 26, 2982-2999..
25. THOMPSON, S. G. AND HIGGINS, J. P. T. (2002). How should meta-regression analyses be undertaken and interpreted? Statistics in Medicine 21, 1559-1573..
26. VIECHTBAUER, W. (2010). Conducting meta-analyses in R with the metafor package. Journal of Statistical Software 36, 1-48..
27. WANG, R., LAGAKOS, S. W., WARE, J. H., HUNTER, D. J. AND DRAZEN, J. M. (2007). Statistics in medicine-reporting of subgroup analyses in clinical trials. New England Journal of Medicine 357, 2189-2194..